News
For the latest media releases and news about Pharmaxis Ltd, please select from the following articles. Material news announcements made by Pharmaxis are first filed with the Australian Securities Exchange (ASX) and are also available on the ASX website.
Pharmaxis Update on Timing of Pre-Clinical Partnering Projects
Pharmaceutical development company Pharmaxis today provided an update on progress in securing partners for its lead drug discovery projects. This activity was announced as part of the May 2013 business plan, and the company had targeted completion of the LOXL2 partnering by mid year.
Read full media release - pdfCommunication from Financier NovaQuest
Pharmaxis advises that on July 4, 2014 it received a notice from NovaQuest Capital Management, an affiliate of NovaQuest Pharma Opportunities Fund III, L.P. (“NovaQuest”), alleging Pharmaxis has breached the Financing Agreement, dated January 30, 2013, between the Company and NovaQuest and that an event of default will occur on August 3, 2014.
The Company strongly rejects the allegation it is in breach, will contest the allegation and take all appropriate steps to ensure that NovaQuest complies fully with its obligations under the Financing Agreement.
Read full media release - pdf